Publikationer Ingrid Glimelius

Publikationer i DiVA

Publikationer i PubMed

Ett urval av våra publikationer:

  1. Ekberg, S, Smedby KE, Albertsson-Lindblad A, Jerkeman M, Weibull C, Glimelius I. Late effects in mantle cell lymphoma patients treated with or without autologous stem cell transplantation. Accepted Blood Advances, Aug 2022.
  2. Sköld C, Koliadi A, Enblad G, Stålberg K, Glimelius I. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes. Int J Cancer. 2022, (5):773-781.
  3. Joana de Matos Rodrigues*, Anna Nikkarinen*, Peter Hollander, Caroline Weibull, Riita Rääty, Arne Kolstad, Rose-Marie Amini, Anna Porwit, Mats Jerkeman, Sara Ek* and Ingrid Glimelius* Infiltration of CD163, PD-L1 and FOXP3 positive cells adversely affects outcome in mantle cell lymphoma (MCL) patients independent of established risk factors. British Journal of Haematology, 2021, 193(3):520-531. *Delat sistaförfattarskap.
  4. Kitahara CM, Slettebø Daltveit D, Ekbom A, Engeland A, Gissler M, Glimelius I, Grotmol T, Trolle Lagerros Y, Madanat-Harjuoja L, Männistö T, Sørensen HT, Troisi R, Bjørge T. Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. Lancet Diabetes Endocrinol. 2021, 9(2):94-105.
  5. Glimelius I, Eloranta S, Ekström K, Jerkeman M, Weibull C. Comorbidities and sex differences in causes of death among mantle cell lymphoma patients – A nationwide population-based cohort study. British Journal of Haematology, 2020, 189(1):106-116.
  6. Biccler J*, Glimelius I*, Eloranta S, Smeland BK, de Nully Brown P, Hjort Jakobsen L, Frederiksen H, Jerkeman M, Fosså A, Andersson ML T, Holte H, Bøgsted M, Christoffer El-Galaly T*, Smedby KE*. Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients with Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study. Journal of Clinical Oncology, 2019, 37:703-713. *Delat första- och sistaförfattarskap
  7. Weibull C, Johansson A, Eloranta S, Smedby KE, Björkholm M, Lambert P, Dickman P, Glimelius I. Contemporarily treated Hodgkin lymphoma patients have childbearing potential in line with matched comparators. Journal of Clinical Oncology, 2018, 36:2718-2725.
  8. Hollander P, Kamper P, Smedby E.K, Enblad G, Mortensen J, Amini RM, d’Amore F, Molin D*, Glimelius I*. High proportion of PD-1+ leukocytes in classical Hodgkin lymphoma microenvironment is associated with inferior prognosis. Blood Advances, 2017, 1(18):1427-1439. *Delat försteförfattarskap
  9. Glimelius I*, Eloranta S*, Ekberg S, Chang T E, Neovius M, Ekström Smedby K. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy. Am J Haematology, 2017, 92(3):251-258. *Delat sistaförfattarskap
  10. Weibull CE, Eloranta S, Ekström Smedby K, Kristinson SY, Björkholm M, Lambert P, Dickman PW*, Glimelius I*. Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma? Journal of Clinical Oncology, 2016, 34(4):337-44. *Delat sistaörfattarskap.
Senast uppdaterad: 2023-01-27